These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12942482)

  • 1. Limited predictive value of inducible sustained ventricular tachycardia for future occurrence of spontaneous ventricular tachycardia in patients with coronary artery disease and relatively preserved cardiac function.
    Matsushita T; Chun S; Liem LB; Friday KJ; Sung RJ
    J Electrocardiol; 2003 Jul; 36(3):205-11. PubMed ID: 12942482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Right ventricular dysfunction predisposes to inducible ventricular tachycardia at electrophysiology studies in patients with acute ST-segment-elevation myocardial infarction and reduced left ventricular ejection fraction.
    Thakkar JB; Zaman S; Byth K; Narayan A; Thiagalingam A; Chow C; Thomas SP; Sivagangabalan G; Farlow D; Barnett R; Kovoor P
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):898-905. PubMed ID: 25108742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term reproducibility of ventricular tachycardia induction with electrophysiological testing in patients with coronary heart disease and depressed left ventricular ejection fraction.
    Brembilla-Perrot B; Houriez P; Claudon O; Preiss JP; Beurrier D; Louis P; Terrier de la Chaise A
    Pacing Clin Electrophysiol; 2000 Jan; 23(1):47-53. PubMed ID: 10666753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia.
    Grimm W; Hoffmann J; Menz V; Luck K; Maisch B
    J Am Coll Cardiol; 1998 Sep; 32(3):739-45. PubMed ID: 9741521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
    Grimm W; Hoffmann J Jü; Müller HH; Maisch B
    J Am Coll Cardiol; 2002 Mar; 39(5):780-7. PubMed ID: 11869841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone therapy for sustained ventricular tachycardia after myocardial infarction: long-term follow-up, risk assessment and predictive value of programmed ventricular stimulation.
    Maury P; Zimmermann M; Metzger J; Reynard C; Dorsaz P; Adamec R
    Int J Cardiol; 2000; 76(2-3):199-210. PubMed ID: 11104875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and therapy for patients with nonsustained ventricular tachycardia.
    Prystowsky EN
    Am J Cardiol; 2000 Nov; 86(9A):34K-39K. PubMed ID: 11084098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative ventricular arrhythmias after cardiac surgery: immediate- and long-term significance.
    Brembilla-Perrot B; Villemot JP; Carteaux JP; Haouzi A; Amrein D; Schöth B; Houriez P; Beurrier D; Djaballah K; Vançon AC; Nippert M
    Pacing Clin Electrophysiol; 2003 Feb; 26(2 Pt 1):619-25. PubMed ID: 12710323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Lampert R; McPherson CA; Clancy JF; Caulin-Glaser TL; Rosenfeld LE; Batsford WP
    J Am Coll Cardiol; 2004 Jun; 43(12):2293-9. PubMed ID: 15193696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The signal averaged electrocardiogram and programmed stimulation in patients with complex ventricular arrhythmias.
    Turitto G; el-Sherif N
    Pacing Clin Electrophysiol; 1990 Dec; 13(12 Pt 2):2156-9. PubMed ID: 1704610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era.
    Hohnloser SH; Klingenheben T; Zabel M; Schöpperl M; Mauss O
    J Am Coll Cardiol; 1999 Jun; 33(7):1895-902. PubMed ID: 10362190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of scar and ischemia to the results of programmed electrophysiological stimulation in patients with coronary artery disease.
    Gradel C; Jain D; Batsford WP; Wackers FJ; Zaret BL
    J Nucl Cardiol; 1997; 4(5):379-86. PubMed ID: 9362014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
    Glikson M; Lipchenca I; Viskin S; Ballman KV; Trusty JM; Gurevitz OT; Luria DM; Eldar M; Hammill SC; Friedman PA
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):658-64. PubMed ID: 15175060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter Ablation of Ventricular Tachycardia as the First-Line Therapy in Patients With Coronary Artery Disease and Preserved Left Ventricular Systolic Function: Long-Term Results.
    Clemens M; Peichl P; Wichterle D; Pavlů L; Čihák R; Aldhoon B; Kautzner J
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1105-10. PubMed ID: 26179108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of inducible very fast ventricular tachycardia (cycle length 200-230 ms) after early reperfusion for ST-segment-elevation myocardial infarction.
    Zaman S; Kumar S; Sullivan J; Narayan A; Thiagalingam A; Ross DL; Kovoor P
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):884-90. PubMed ID: 23995117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocardial mapping during sinus rhythm in patients with coronary artery disease and nonsustained ventricular tachycardia.
    Buxton AE; Kleiman RB; Kindwall KE; Josephson ME
    Am J Cardiol; 1993 Mar; 71(8):695-8. PubMed ID: 8447267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.